A new potential way to treat brain tumours is on the horizon...

A new potential way to treat brain tumours is on the horizon...
Results of early clinical trials suggest that Chimeric Antigen Receptor -T (CAR-T) cells can be adapted successfully to target brain tumours. A phase 1 analysis of one next-generation CAR T-cell therapy, reported at the AACR Virtual Special Conference on Brain Cancer, showed it may target and kill tumour cells while eliciting an immune system response. Making the transition from blood cancers to solid tumours, which has been challenging, is a focus of current research and this includes de...

Comments

Popular posts from this blog

Grand Connection Supports Small Businesses Impacted by Pandemic.

Advance information: World premiere of the QUANTRON QARGO 4 EV in the light truck segment at QUANTRON Q-Days from April 26-28, 2022

BYTON Plant Open Day: reaffirming start of series production by end of 2019